RESEARCH TRIANGLE PARK, N.C. and STAMFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, and BEKHealth, a number one medical analysis platform, at the moment introduced a partnership that may allow Science 37 to entry the EMR knowledge, completely, throughout its community of greater than 35 thousand group suppliers, masking greater than 35 million affected person lives–increasing participant entry, accelerating enrollment, and doubtlessly decreasing time to marketplace for vital investigational therapies and therapies.
“As a digital web site, Science 37 is within the distinctive place to have the ability to entry sufferers which might be unavailable by a standard web site community,” mentioned Darcy Forman, Chief Supply Officer at Science 37. “Instantly accessing the EMR knowledge throughout our group suppliers permits us to get far more exact at feasibility and to speed up enrollment by one in every of our most prolific affected person recruitment channels.”
At present, lower than 3% of all suppliers are medical analysis investigators. Given their restricted entry to sufferers, lower than 8% of sufferers are ever contacted to take part in medical analysis. Through the use of BEKHealth’s A.I. know-how to go looking the digital medical data of sufferers inside Science 37’s in depth group supplier community, Science 37 can match particular person sufferers to particular medical trial cohorts. This expands entry to incorporate sufferers who weren’t beforehand in a position to take part, growing each the quantity of contributors and the pace of enrollment.
“We’re delighted to work with Science 37 to broaden entry to medical trials, notably inside under-represented communities,” mentioned Jason Baumgartner, President and CEO at BEKHealth. “By making use of our knowledge, know-how, and instruments to Science 37’s flourishing group supplier community, we’re in a position to assist their mission to offer entry to sufferers who would usually not have publicity to medical analysis. With this partnership, we’ll have the ability to goal the greater than 90% of sufferers in healthcare programs who’re historically neglected.”
About Science 37
Science 37, Inc.’s (Nasdaq: SNCE) mission is to speed up medical analysis by enabling common entry for sufferers. In 2014, we pioneered decentralized medical trials, and we proceed to guide, delivering quicker, extra inclusive, patient-centric trials, by eradicating limitations to entry by a tech-enabled digital web site. The Science 37 Metasite™ leverages a unified set of individuals, processes, and know-how, delivering higher consistency and regulatory-quality knowledge. With probably the most medical and operational expertise throughout therapeutic areas, Science 37 has enabled as much as 21x quicker enrollment, 28% higher retention, and 3x extra range vs. the normal web site. To be taught extra, go to www.science37.com, or e-mail firstname.lastname@example.org.
BEKHealth Company is a privately held, venture-backed enterprise based mostly in Connecticut. BEKHealth was based to serve a core want of medical analysis—extra correct and automatic trial feasibility and affected person trial matching. By combining a proprietary AI-powered EMR data-processing engine with easy-to-use and impactful workflow options, we offer websites and CROs the power to realize “the final mile” to recruit the best sufferers extra quickly. For extra info, go to www.bekhealth.com.
Cautionary Notice Concerning Ahead-Trying Statements
This press launch incorporates sure forward-looking statements throughout the which means of the federal securities legal guidelines, together with statements concerning the merchandise supplied by Science 37, its gross sales pipeline and the markets during which it operates. These forward-looking statements typically are recognized by the phrases “imagine,” “venture,” “count on,” “anticipate,” “estimate,” “intend,” “technique,” “future,” “alternative,” “plan,” “could,” “ought to,” “will,” “would,” “shall be,” “will proceed,” “will possible end result” and comparable expressions. Ahead-looking statements are predictions, projections and different statements about future occasions which might be based mostly on present expectations and assumptions and, consequently, are topic to dangers and uncertainties. Many components may trigger precise future occasions to vary materially from the forward-looking statements on this press launch, together with however not restricted to: (i) the power to keep up the itemizing of Science 37’s securities on Nasdaq, (ii) volatility within the value of Science 37’s securities resulting from quite a lot of components, together with modifications within the aggressive and extremely regulated industries during which Science 37 operates, variations in efficiency throughout rivals, modifications in legal guidelines and rules affecting Science 37’s enterprise and modifications in its capital construction, (iii) the power to implement enterprise plans, forecasts, and different expectations, and to establish and understand further alternatives, (iv) the danger that Science 37 could by no means obtain or maintain profitability, (v) the danger that Science 37 might want to increase further capital to execute its marketing strategy, which might not be out there on acceptable phrases or in any respect, (vi) failure to comprehend anticipated value financial savings, and (vii) the potential adversarial results of the continuing world COVID-19 pandemic. The foregoing checklist of things shouldn’t be exhaustive. You need to fastidiously think about the foregoing components and the opposite dangers and uncertainties described within the “Threat Elements” part of our Annual Report on Type 10-Ok for the fiscal yr ended December 31, 2021 filed with the U.S. Securities and Alternate Fee (the “SEC”) on March 22, 2022 and in our different paperwork filed by Science 37 every now and then with the SEC. These filings establish and tackle different vital dangers and uncertainties that would trigger precise occasions and outcomes to vary materially from these contained within the forward-looking statements. Ahead-looking statements communicate solely as of the date they’re made. Readers are cautioned to not put undue reliance on forward-looking statements, and Science 37 assumes no obligation and doesn’t intend to replace or revise these forward-looking statements, whether or not on account of new info, future occasions, or in any other case, besides as required by legislation. Science 37 doesn’t give any assurance that Science 37 will obtain its expectations.
GKC for BEKHealth